Efficacy of acupuncture treatments on frequency and intensity of pain attacks in patients with idiopathic or classic trigeminal neuralgia - ACUTRIG ACUpuncture in TRIGeminal neuralgia

Charité Campus Charité Mitte0 个研究点目标入组 20 人开始时间: 2019年9月6日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Confirmed diagnosis of idiopathic or classical trigeminal neuralgia
•2.Age between 18- 85yrs
•3.At least 3 attacks per day, with an intensity of at least 4 on a NRS, on at least 4 days per week
•4.Stable (unchanged dose since 4 weeks) prophylactic medication (e.g.: carbamazepine, oxcarbazepine, baclofen, phenytoin, gabapentin, lamotrigine etc.)
•5.Stable concomitant medication with possible influence on trigeminal neuralgia (antidepressants, duloxetine)
•6.Patient is ready to take part in randomization process, and willing to fill out diaries
•7.Patient provided written and oral consent to participation in study

•1.Symptomatic or secondary trigeminal neuralgia (due to Multiple Sclerosis, tumors etc.) or additional SUNCT, SUNA or paroxysmal hemicranias or cluster headaches
•2.Use of opioids or opiates before inclusion into study
•3.Frequent or chronic THC or Cannabis use before inclusion into study or during study
•4.Psychotherapy during three months before study or planned during study participation
•5.Additional complementary or alternative treatment 4 weeks before inclusion into study or during study participation
•new 5a: acupuncture in the 12 weeks before study onset.
•6.For female patients pregnancy or breast- feeding
•7.Somatic or mental illness that prevent from participation in the study (e.g. bleeding disorders, oral anticoagulation, psychosis)
•8.Alcohol or drug abuse
•9.Missing knowledge of German language
•10.Participation in other interventional studies
•11.Ongoing incapacity pension process
•12.Planned rehabilitation during study participation

发起方

Charité Campus Charité Mitte